Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Biofrontera Inc.

Biofrontera Inc. (BFRIW) Stock Overview

Explore Biofrontera Inc.’s financial performance, market position, analyst ratings, and future outlook.

BFRIW●NASDAQ
HealthcareDrug Manufacturers - Specialty & Generic
$0.03
$0.00(0.40%)
U.S. Market opens in 65h 16m

Biofrontera Inc. (BFRIW)

Meyka AI Score

Z

Key Financials

Market Cap14.2M
P/E Ratio-2.22
EPS (TTM)$-1.12
ROE-1.28%
Fundamental Analysis

AI Price Forecasts

1 Month$-0.01
3 Months$0.01
1 Year Target$0.87

BFRIW Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Biofrontera Inc. (NASDAQ: BFRIW) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Biofrontera Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of BFRIW on the NASDAQ shows an RSI of 47.28, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $0.87 for the NASDAQ listing.

Key metrics behind Biofrontera Inc.'s NASDAQ-traded stock include a P/E ratio of -2.22 and a market capitalization of 14.2M. Combined with our AI analysis, these give both institutional and retail investors a clear view of BFRIW on the NASDAQ.

Price Performance (NASDAQ: BFRIW)

1-Day Change
N/A
5-Day Change
7.33%
1-Month Change
-14.43%
3-Month Change
12.67%
6-Month Change
-60.73%
Year-to-Date (YTD) Change
-72.33%
1-Year Change
-79.66%
3-Year Change
-53.80%
5-Year Change
-98.07%
All-Time (Max) Change
-98.07%

Contact Information

https://www.biofrontera-us.com
781-245-1325
660 Main Street, Woburn, MA, 01801

Company Facts

920 Employees
IPO DateOct 29, 2021
CountryUS
Actively Trading

Frequently Asked Questions